Gemina Labs

About:

Gemina Labs is a transformative biochemistry firm that develops next-generation testing platforms for detecting pathogens.

Website: https://www.geminalabs.com/

Top Investors: Syniad Innovations

Description:

Gemina Labs has created and patented a transformative bio-chemistry platform that powers next-generation testing platforms for detecting a wide range of pathogens that affect humans and animals. The tests are quick, inexpensive, and accurate, and they can be self-administered, providing consumers with immediate results. They are developers of novel surface binders, which are critical to the speed, affordability, and accuracy of the pathogen detection platform.

Total Funding Amount:

9M CAD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2017-01-01

Contact Email:

investor(AT)geminalabs.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-11-13

IPO Status:

Public

Industries:

© 2025 bioDAO.ai